University of Miami School of Medicine
Miami, FL
MD
University of Illinois Chicago
Chicago, IL
- Internal Medicine
Cleveland Clinic
Cleveland, OH
- Gastroenterology and Hepatology
Northwestern Memorial Hospital
Chicago, IL
- Transplant Hepatology
Survival Outcomes of Radiofrequency Ablation for Intrahepatic Cholangiocarcinoma from the SEER Database: Comparison with Radiotherapy and Resection.
Survival Outcomes of Radiofrequency Ablation for Intrahepatic Cholangiocarcinoma from the SEER Database: Comparison with Radiotherapy and Resection. J Vasc Interv Radiol. 2024 Nov 02.
PMID: 39491643
Guidelines in Practice: Focal Liver Lesions.
Guidelines in Practice: Focal Liver Lesions. Am J Gastroenterol. 2024 Oct 21.
PMID: 39436238
Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma.
Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. JAMA. 2024 09 24; 332(12):1013-1014.
PMID: 39207780
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction.
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction. JAMA Oncol. 2024 Sep 01; 10(9):1253-1258.
PMID: 39023864
Targeted therapies in hepatocellular carcinoma: past, present, and future.
Targeted therapies in hepatocellular carcinoma: past, present, and future. Front Oncol. 2024; 14:1432423.
PMID: 39267840
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients with Unresectable HCC.
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients with Unresectable HCC. Clin Gastroenterol Hepatol. 2024 Jul 30.
PMID: 39089513
The rise of multidisciplinary clinics in hepatology: A practical, how-to-guide, and review of the literature.
The rise of multidisciplinary clinics in hepatology: A practical, how-to-guide, and review of the literature. Hepatology. 2024 Jul 30.
PMID: 39212328
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment. Hepatology. 2024 Jul 19.
PMID: 39028886
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future.
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future. Hepatol Commun. 2024 06 01; 8(6).
PMID: 38829199
Considerations in gender-affirming hormone therapy in transgender and gender diverse patients undergoing liver transplantation.
Considerations in gender-affirming hormone therapy in transgender and gender diverse patients undergoing liver transplantation. Am J Transplant. 2024 Sep; 24(9):1567-1572.
PMID: 38729612